Palatin Technologies (PTN): Price to Earnings Adjusted for Growth Rate

Corporate company logo of Palatin Technologies (PTN)

Palatin Technologies (PTN) share price dynamics are subject to the influence of geopolitics and regulatory barriers during drug testing. The fair value assessment based on the PEG ratio visualizes these risks, where 0.00 determines the current value of the metric. Stable demand for female libido treatments protects the company from GDP downturns, while the efficient use of external CRO laboratories accelerates the verification of new therapeutic solutions.

PTN Palatin Technologies: PEG Multiple in the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for Palatin Technologies (PTN)

- market price and analyst price targets:
Stock Quotes Palatin Technologies Inc|PTN - Price Target Chart
- stock exchange capitalization data:
Market Value Palatin|PTN - Total Company Value
- shareholders' equity book value data:
Accounting Value per Share Palatin Technologies|PTN - Book Capitalization|Market-to-Book Ratio palatin.com|PTN - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio Palatin Technologies|PTN - Long-Term Debt to Equity|Current Liabilities to Equity palatin.com|PTN - Company Aggregate Debts|Debts to Book Capitalization Palatin|PTN - Company Long-Term Debt|Company Short-Term Debt Palatin Technologies|Quick Ratio palatin.com
- business earnings and investment ratios data:
PTN - Net Income|Future Net Profit Palatin Technologies|PTN - P/E Multiple|Market Cap to Projected Earnings Palatin Corp|PTN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Palatin|PTN - Operating profit before deduction of amortization|Earnings per share for the trailing year Palatin Technologies|PTN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months palatin.com|PTN - Earnings growth in current year|Expected net earnings per share growth next year Palatin Technologies
General company analysis:PTN Palatin Technologies Inc
Manufactured products of Palatin Corp

The PEG ratio measures the efficiency of market value relative to earnings growth, where values below one signal that an asset is undervalued. In the context of scaling the clinical portfolio of Palatin Technologies (PTN), correlating the P/E ratio with growth expectations allows for an assessment of the fair value of the shares as drugs advance toward Phase 3, thereby determining the biotech's investment potential.

Competitors of Palatin Technologies

Price/Earnings to Growth Multiple Organon & Co OGN|Price/Earnings to Growth Ratio Dare Bioscience Inc. DARE|TherapeuticsMD Inc (TXMD) - Price to Earnings Adjusted for Growth Rate